Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
05/2003
05/21/2003EP1311664A2 Microtubule-associated proteins and tubulins
05/21/2003EP1311663A2 Claudin polypeptides
05/21/2003EP1311661A2 Enhanced homologous recombination mediated by lambda recombination proteins
05/21/2003EP1311547A2 Diagnosis and treatment of cardiovascular conditions
05/21/2003EP1311540A2 Altered ospa of borrelia burgdorferi
05/21/2003EP1311539A2 Pro-apoptotic fragments of the dengue virus envelope glycoproteins
05/21/2003EP1311537A2 Identification of a cam-kinase ii inhibitor
05/21/2003EP1311529A1 Novel tumor suppressor encoding nucleic acid, ptx1, and methods of use thereof
05/21/2003EP1311511A1 Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting erab or hadh2 activity
05/21/2003EP1311332A1 Method and apparatus for the concentration of fluid-borne pathogens
05/21/2003EP1311163A2 Improved insecticidal bacteria, and methods for making and using them
05/21/2003EP1311153A2 High temperature cryogenic preservation of biologically active material
05/21/2003EP1015593B1 Hepatitis b virus polypeptides
05/21/2003EP0866801B1 Cyclopeptolides
05/21/2003EP0820337B1 Centrifugal fermentation process
05/21/2003EP0817640B1 Use of epithelial adhesive lactobacilli
05/21/2003EP0707650B1 Process for producing human relaxin
05/21/2003EP0573551B1 Serine-rich peptide linkers
05/21/2003EP0472722B1 Dnas encoding plant desaturases and their uses
05/21/2003EP0411031B1 THE HUMAN C3b/C4b RECEPTOR (CR1)
05/21/2003CN1419600A Recombinant adenylcyclase and use thereof for screening molecules with
05/21/2003CN1419596A Method of culturing microorganism
05/21/2003CN1419564A Proteins comprising conserved regions of neisseria meningitidis surface antigen NhhA
05/21/2003CN1419416A Cultured protein hydrolysate
05/21/2003CN1418949A Gene engineering strain MI033WZ expression M1033 GI mutation enzyme GIG 38P and construction method thereof
05/21/2003CN1418948A Rhodococcus erythropolis and application in removing sulfur element in surfide thereof
05/21/2003CN1418947A Application of benzimidazol resistance gene in trichodermin
05/21/2003CN1418946A Method for semiaseptic culturing heterotrophic chlorella
05/21/2003CN1109104C Process for solid state fermentation of monascus and fermenting equipment thereof
05/21/2003CN1109103C Artificial culture of jiuzhou caterpillar fungus and the application of its sporophore
05/21/2003CN1108789C Liposomes contg. particulate materials
05/20/2003US6566583 Schizochytrium PKS genes
05/20/2003US6566512 ARV1, a protein involved in sterol uptake and sterol homeostasis in the budding yeast, S-cerevisiae, and a functional human ARV1
05/20/2003US6566498 Proteins for use in the treatment of thrombosis and tumor metastisis
05/20/2003US6566328 Administering to the patient a therapeutically effective amount of a polypeptide for therapy of patient in need of agonist effect of human growth hormone
05/20/2003US6566325 And isolated nucleic acids containing coding regions of genes encoding such proteins; for use in gene therapy treatment of cancer, autoimmune diseases, viral diseases
05/20/2003US6566136 Immortalized cell line derived from normal human skin tissues
05/20/2003US6566123 Biomass containing Thraustochytriales microflora
05/20/2003US6566122 Super-secreting saccharomyces cerevisiae strains
05/20/2003US6566121 Genetically engineered microorganism for use as tools in the generation and expression of heterolgous proteins
05/20/2003US6566120 Contacting compactin with an agent derived from Actinomadura under conditions in which agent converts compactin to pravastatin; anticholesterol agent
05/20/2003US6566116 Enzymatic polypeptide for use in the treatment of diabetic nephropathy, glomerulonephritis, fibrosis, liver and kidney disorders, osteoporosis and lung disorders
05/20/2003US6566114 Mannanases
05/20/2003US6566113 Polypeptide having cellobiohydrolase activity
05/20/2003US6566110 Nucleotide sequences coding polypeptide for use tool in halogenating compounds
05/20/2003US6566109 Gene for thermostable glucokinase, recombinant vector containing the same, transformant containing the recombinant vector and process for producing thermostable glucokinase using the transformant
05/20/2003US6566108 Genetically engineered cell for use in the expression of heterologous proteins and particles
05/20/2003US6566107 Microorganism for use in the conversion of a hydantoin into a racemic compound for use in generation of ethanol
05/20/2003US6566106 Process for the isolation of clavulanic acid and of pharmaceutically acceptable salts thereof
05/20/2003US6566105 Process for the production of D-α-amino acids
05/20/2003US6566100 Glycosyltransferase protein for use in generation of preferential antibiotic
05/20/2003US6566096 Mammalian EDG-7 receptor homologs
05/20/2003US6566087 Detection of preferential enzymatic polypeptide; obtain sample containing enzymatic polypeptide, expose to modulator, monitor binding, detect adjustment in enzyme activity
05/20/2003US6566075 Methods for detecting human platelet-derived growth factor receptor agonists and antagonists
05/20/2003US6566066 Aquaporin-8 variant
05/20/2003US6566063 Diagnosing cancer in cells; obtain cells, monitor expression of gland-specific transcription factor, compare to control, evaluate for cancer
05/20/2003US6566062 Method for identifying a nucleic acid
05/20/2003US6566057 Methods and compositions for peptide libraries displayed on light-emitting scaffolds
05/20/2003US6566048 Acetyl-COA-carboxylase from Candida albicans
05/20/2003US6565857 Coding human leukocyte antigen; anticancer, antitumor agent
05/20/2003US6565856 Polypeptide; inducting immunology response
05/20/2003US6565855 Polypeptides; genetic engineering
05/20/2003US6565852 Tumor antigen; vaccine; antitumor, anticarcinogenic agents
05/20/2003US6565848 Cadherin-like asymmetry protein-1, and methods for its use
05/20/2003US6565846 Microbial strains of pseudomonas, bacillus and enterobacter/in agricultural chemical compositions
05/20/2003CA2160166C Lactic acid bacterial suppressor mutants and their use as selective markers and as means of containment in lactic acid bacteria
05/15/2003WO2003041128A2 Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells
05/15/2003WO2003040687A2 Isolation and purification of nucleic acids
05/15/2003WO2003040681A2 Genes coding for metabolic pathway proteins
05/15/2003WO2003040410A1 Detection of hybridization oligonucleotide microarray through covalently labeling microarray probe
05/15/2003WO2003040391A2 Method for producing and identifying soluble protein domains
05/15/2003WO2003040379A2 Modulating urea degradation in wine yeast
05/15/2003WO2003040376A1 Method for site-directed mutagenesis of nucleic acid molecules using a single primer
05/15/2003WO2003040373A2 Production of l-lysine by genetically modified corynebacterium glutamicum strains
05/15/2003WO2003040372A2 Polynucleotides and polypeptides involved in clavulinic acid biosynthesis and use thereof
05/15/2003WO2003040371A1 Novel g protein-coupled receptor protein and dna thereof
05/15/2003WO2003040357A2 Genes coding for phosphoenolpyruvate-sugar-phosphotransferase proteins
05/15/2003WO2003040352A1 Non-sporulating bacillus subtilis having parts of the gene encoding sigma g deleted
05/15/2003WO2003040351A1 A novel non-antibiotic strategy against ogip infections based on an activated cereal product or ferric quinate
05/15/2003WO2003040349A1 Mixture of propionibacterium jensenii and lactobacillus sp. with with antimicrobial activities for the use as natural preservation system
05/15/2003WO2003040348A1 Schimizuomyces sp. sjm, the method of culture thereof and the composition for plant growth promoting including culture solution thereof
05/15/2003WO2003040345A2 Type 2 cytokine receptor and nucleic acids encoding same
05/15/2003WO2003040329A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/15/2003WO2003040313A2 Il-21 antagonists
05/15/2003WO2003040310A2 Novel epidermal growth factor protein and gene, and methods of use therefor
05/15/2003WO2003040309A2 Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
05/15/2003WO2003040293A2 Genes coding for stress resistance and tolerance proteins
05/15/2003WO2003040292A2 Genes encoding for membrane synthesis and membrane transport proteins
05/15/2003WO2003040291A2 Genes encoding for carbon metabolism and energy-producing proteins
05/15/2003WO2003040290A2 Genes from corynebacterium glutamicum that code for homeostasis proteins and for adaptation proteins
05/15/2003WO2003040289A2 Genes coding for dna replication proteins and for proteins related to pathogenesis
05/15/2003WO2003040187A1 Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof
05/15/2003WO2003040181A2 Genes from the corynebacterium glutamicum coding for regulatory proteins
05/15/2003WO2003040180A2 Genes of corynebacterium glutamicum encoding for genetic stability, gene expression and folding proteins
05/15/2003WO2003040179A1 High level constitutive production of anthrax protective antigen
05/15/2003WO2003040170A2 Antibodies to cd40
05/15/2003WO2003039726A2 Method for forming catalytic sites at the surface of a support
05/15/2003WO2003039484A2 Novel compositions and methods for cancer
05/15/2003WO2003039260A2 Probiotic compositions
05/15/2003WO2002097032A3 Proteins associated with cell growth, differentiation, and death